Sites And Sponsors: How To Split The Risk And Reduce Patient Screening Failures

Clinical trial screen failures happen when potential participants consent to join a trial but are subsequently determined to be ineligible in the screening process or decide to withdraw consent. As this process is costly and time-consuming for sites and sponsors, both stakeholders are highly motivated to mitigate screen failure rates to reduce the overall risk for the clinical trial. This article explores ways stakeholders can work together to reduce the risk of screen failures and increase clinical trial success.